Sixty years after her death, cells from Henrietta Lacks – born on this day in 1920 – live on in laboratories across the world in cell culture. Unbeknownst to the patient, a sample of her aggressive cervical cancer was cultured for research purposes before her death. The cells divided indefinitely and became the first immortal cell line. Known as HeLa (pictured, nuclei shown in red), today the cancer cell line is one of thousands available to researchers. HeLa’s immortality allows scientists to study the same cells repetitively. The culture has facilitated a host of breakthroughs including in vitro fertilisation (IVF) and development of the polio vaccine. HeLa cells continue to be a favourite tool in biomedicine. An estimated twenty tonnes have been grown globally and experiments with HeLa have featured in thousands of biological patents. The ethical debate surrounding the ownership of Henrietta’s cells rages on.
Written by Katie Tomlinson
BPoD stands for Biomedical Picture of the Day. Managed by the MRC London Institute of Medical Sciences the website aims to engage everyone, young and old, in the wonders of biomedicine. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.